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SUMMARY
Objective: Patients with peripheral artery disease (PAD) or coronary artery disease (CAD) must 
have their risk factors rigorously controlled, but there is a gap between practice and ideal. This 
study aimed to demonstrate how cardiovascular prevention is performed for these patients in a 
Brazilian university hospital, and to identify predictors of good practice. Methods: 192 patients 
with CAD or PAD were included in this transversal study. Six prevention goals were analyzed: 1) 
systolic blood pressure < 140 mmHg; 2) diastolic blood pressure < 90 mmHg; 3) LDL < 100 mg/dL; 
4) HDL > 40 mg/dL for men/ > 50 mg/dL for women; 5) not smoking; 6) regular practice of aerobic 
exercise. Results: The mean age of the patients was 65.7 years, and 60% were men. The percentage 
of patients that achieved goals 1 to 6 was 57.3%, 67.2%, 40.1%, 27.6%, 88.5%, and 25%, respectively. 
The average number of goals achieved by patients was 3.06 ± 1.31. When asked about the reason 
for being treated, 182(94.8%) patients claimed to know about their disease, but when the diagnosis 
reported by the patients with the physician’s diagnosis were compared, it was discordant in 12% 
of cases. The average number of goals achieved by patients was 2.67 and 3.46 for the PAD and the 
CAD group, respectively. The independent predictors of a higher number of goals/patient were: 
male gender (p = 0.011), hospitalization (p < 0.0001), CAD diagnosis (p = 0.011), knowing the 
reason for treatment (p = 0.028), and receiving prescription of β-blocker (p = 0.011). Conclusion: 
Even in an university hospital, prevention is far from ideal. Efforts to increase patients’ awareness 
should be stimulated, and can possibly improve the effectiveness of preventive measures.
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RESUMO
Melhora da prevenção cardiovascular pelo conhecimento do paciente
Objetivo: Pacientes com doença arterial periférica (DAP) ou doença arterial coronariana (DAC) 
necessitam de um controle rigoroso dos seus fatores de risco, mas essa prática ainda está muito 
aquém da ideal. O objetivo deste estudo foi verificar como é feita a prevenção cardiovascular nesses 
pacientes em um hospital universitário no Brasil e identificar os preditores de melhor prevenção se-
cundária. Métodos: Trata-se de estudo transversal, com 192 pacientes portadores de DAC ou DAP. 
Foram analisadas seis metas a serem atingidas: 1) pressão arterial sistólica < 140 mmHg; 2) pressão 
arterial diastólica < 90 mmHg; 3) LDL < 100 mg/dL; 4) HDL > 40 mg/dL para homens/> 50 mg/dL 
para mulheres; 5) não fumar; 6) prática de exercício físico aeróbico regular. Resultados: A idade 
média dos pacientes é 65,7 anos e 60% são do sexo masculino. A porcentagem dos pacientes que 
atingiram de 1 a 6 metas foi 57,3%; 67,2%; 40,1%; 27,6%; 88,5% e 25%, respectivamente. O nú-
mero médio de metas atingidas por paciente foi 2,67 e 3,46 para os pacientes com DAP e DAC, 
respectivamente. Os preditores independentes de maior número de metas/paciente foram: sexo 
masculino (p = 0,011), estar internado (p < 0,001), diagnóstico de DAC (p = 0,011), saber o motivo 
do tratamento (p = 0,028) e receber prescrição de β-bloqueador (p = 0,011). Conclusão: Mesmo 
em um hospital universitário, a prevenção encontra-se longe da ideal. Esforços para aumentar a 
conscientização do paciente devem ser estimulados e podem possivelmente melhorar a efetividade 
das medidas preventivas.
Unitermos: Aterosclerose; fatores de risco; doença arterial periférica; doenças da coronária; 
prevenção.
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INTRODUCTION
Patients with peripheral artery disease (PAD) or significant 
coronary artery disease (CAD) are considered at high-risk 
for cardiac and cerebrovascular events1. The common un-
derlying atherosclerotic process and the concomitance of 
advanced stages in diverse arterial systems justify why pa-
tients with PAD are in the same risk category of patients 
with known CAD. Actually, it has been suggested that the 
long-term prognosis of PAD patients can be even worse 
than that of CAD patients’2.  
The worldwide prevalence of PAD is high, ranging from 
10.5% to 20% in the elderly population3-5. Considering that 
even asymptomatic patients with confirmed PAD have a 
substantial increase in their cardiovascular risk, PAD is a 
major public health problem. The high importance of this 
disease has influenced many different medical societies to 
develop guidelines for appropriate risk factor control1,6,7. 
However, those recommendations are frequently not 
translated into clinical practice, as already demonstrated 
in this context 8-13, and in other clinical situations14,15. 
Several studies display multifactorial reasons for this 
gap, varying from bad medical practice to poor patient 
treatment adherence8-11,16,17. Moreover, it has been specu-
lated that the patient’s awareness of their condition may 
influence the effectiveness of secondary prevention18.
There is a lack of information regarding the implemen-
tation of cardiovascular prevention guidelines for specific 
populations in Brazil. Hence, the objectives of this study 
were to analyze the quality of secondary prevention in 
PAD and in CAD patients, and to identify the predictors of 
better quality, at the Clinics Hospital of the Medical School 
of the Universidade de São Paulo in São Paulo – Brazil. 
METHODS
This is an observational and transversal study that was 
conducted at the Medical School of the Universidade de 
São Paulo, in the vascular surgery service, and in the heart 
institute of the Clinics Hospital. The protocol had been 
previously approved by the local ethics committee. 
The selection criteria were the presence of stable CAD 
for the cardiology patients,  whereas at the vascular sur-
gery, it was stable aortic disease (aneurysm/ dissection), 
carotid obstruction, or peripheral obstructive arterial dis-
ease. Patients were randomly selected at the outpatient 
clinic and at the hospital wards and were invited by medi-
cal students to participate in the study. After signing an 
informed consent, patients were interviewed and had their 
medical charts analyzed.
The questionnaire was designed to identify the self-re-
ported rate of the traditional risk factors for atherosclero-
sis (hypertension, dyslipidemia, diabetes, smoking, physi-
cal inactivity) and whether patients had received medical 
counseling regarding lifestyle modification.
Patients were also asked to report their medical di-
agnosis (“Do you know the main reason why you are 
treated for in this clinic?”)  and whether they knew the 
importance of cardiovascular prevention (e.g.:, vascular 
patients were asked “Do you know that if you exercise, 
quit smoking, control your blood pressure and cholester-
ol levels, besides the benefits for your vascular problem, 
you can also prevent stroke and myocardial infarction?”).
The diagnosis registered in the medical chart was 
compared to the patient’s self reported diagnosis. The 
last available data in the past two years for blood pres-
sure levels, lipid profile, fasting glucose, glycated hemo-
globin (HbA1c), and prescription of anti-platelet agents, 
β-blockers, statins, and angiotensin conversion enzyme-
inhibitors (ACE-i) were recorded.    
Six desirable prevention goals were defined for ev-
ery patient: (1) systolic blood pressure < 140 mmHg, (2) 
diastolic blood pressure < 90  mmHg, (3) LDL-choles-
terol < 100 mg/dL, (4) HDL-cholesterol > 40 mg/dL for 
men and > 50 mg/dL for women, (5) not smoking, and 
(6) practice of aerobic exercise1,7. For diabetic patients, 
the HbA1c goal was <  7%. Considering that lipid pro-
file and blood pressure should ideally be checked at least 
every six months, patients who had not been tested in 
the past two years were considered as not achieving the 
blood pressure and/or lipid goals. The number of goals 
achieved per patient was calculated and statistical analy-
sis was performed to identify the predictors of a greater 
average number of goals. 
STATISTICAL ANALYSIS
A descriptive analysis of the demographic and risk fac-
tors characteristics was initially performed for the entire 
cohort of patients; those characteristics were then com-
pared between the PAD and CAD groups. Variables were 
tested for normal distribution; Student’s t-test was applied 
for the continuous variables (described as mean values 
and standard deviation) and the chi-squared or Fisher’s 
exact test for categorical variables (described as percent-
age values). When variables did not pass in the normality 
test, the non-parametric equivalents were applied.  
A linear regression model was applied to identify the 
predictors of a greater number of goals achieved by pa-
tient. Variables with a previously assumed association to 
the independent factor (e.g. gender18,19) or those with a 
statistical significance level that reached a pre-defined 
p < 0.10 in the univariate test were included in the mul-
tivariate analysis.
Statistical significance was considered as a two-tailed 
probability of less than 0.05. All statistical analyses were 
performed using the Statistical Package for Social Sci-
ences (SPSS) 17.0 software. 
VERONICA Y. P. CHANG ET AL.
552 Rev Assoc Med Bras 2012; 58(5):550-556
RESULTS
Between March and November of 2010, 200 patients were 
analyzed, and eight were excluded for not having athero-
sclerosis as the primary cause for cardiovascular disease. 
From the remaining 192, 93 were selected from the vas-
cular surgery clinic (PAD), and 99 from the cardiology 
clinic (CAD). Their mean age was 65.66  ±  10.50 years, 
77 patients (40%) were women; 77.6% had hypertension, 
75% of them were sedentary, 65.7% were current or former 
smokers, 57.3% had dyslipidemia, and 39.1% had diabetes. 
Nearly half of them were hospitalized (49%) for elective 
myocardial revascularization or elective vascular surgical 
procedures. For PAD patients, the main clinical manifes-
tation of atherosclerotic disease was aortic disease (aneu-
rysm or dissection) in 50%, followed by peripheral artery 
disease in 22.6%, and carotid obstruction in 20.4% of the 
cases. The remaining 7% were treated by vascular surgeons 
because of other atherosclerotic problems, such as popli-
teal aneurysm or renovascular disease. Almost 60% of the 
patients were treated by two or more physicians. 
Although 70.8% of the patients have reported that they 
had received dietary counseling, only 44.8% reported fol-
lowing a balanced diet. As for aerobic exercise, 57.8% were 
encouraged to exercise but only 25% reported practicing it 
on a regular basis. Regarding medical advice for smoking 
cessation, 65% of the current and former smokers informed 
they were encouraged to quit smoking by their physicians. 
Statin was the most prescribed class of medication 
(91.1% of the patients were receiving statins), followed by 
aspirin (87.5%), beta-blockers (67.2%), angiotensin con-
version enzyme inhibitor (54.7%), and clopidogrel (5.2%). 
16 patients (8.3%) reported that they did not take medica-
tions regularly. 
The six prevention goals previously defined for this study 
(1) systolic blood pressure < 140 mmHg, (2) diastolic blood 
pressure < 90 mmHg, (3) LDL-cholesterol < 100 mg/dL, 
(4) HDL-cholesterol > 40 mg/dL for men and > 50 mg/dL 
for women, (5) not smoking, and (6) practice of aerobic 
exercise, were achieved in 57.3%, 67.2%, 40.1%, 27.6%, 
88.5%, and 25%, respectively. The average number of goals 
achieved by patient was 3.06 ± 1.31. Only 17.3% of the dia-
betic patients had HbA1c < 7%. 
When asked about the reason for being treated, 182 (94.8%) 
patients claimed to know their disease, but when the diagno-
sis reported by the patients were compared with the diagnosis 
recorded by the physicians in medical charts, it was discordant 
for 24 patients (12%). Almost 23% of the patients were not 
aware of the importance of cardiovascular prevention.
The comparison of the demographic characteristics be-
tween vascular and cardiology patients is represented on 
Table 1. There were more diabetic patients in the cardiol-
ogy group, and cardiology patients received dietary coun-
seling and protective medications more frequently than 
vascular patients. In the vascular group, there were more 
current smokers, and patients were more frequently treat-
ed by another physician. The rate of discordance between 
the patients self-reported diagnosis and thaton medical 
charts was greater in the vascular surgery group.
Twenty- two (23.6%) patients in the PAD group and 
14 (14.1%) cardiology (CAD) patients did not have labo-
ratorial exams for the past two years; 46 (49.5%) vascular 
patients did not have blood pressure measurement, in con-
trast with the cardiology group, in which only one patient 
(1%) did not have blood pressure measurement. However, 
when comparing diabetes monitoring, namely HbA1c, 
there was an inversion: 16% of the diabetics from vascular 
surgery did not have HbA1c measurement, while 30% of 
the diabetics in the cardiology group did not have this test 
for the past two years. The average values of blood pressure 
and lipid profile are displayed on Table 1. 
As represented on Figure 1, except for the HDL-
cholesterol goal, all other goals were more frequently 
achieved by cardiology patients. There was a significant 
difference between the two groups regarding the average 
number of goals achieved per patient (vascular = 2.67 
and cardiology = 3.40; p < 0.001).
A series of univariate analysis were performed to deter-
mine the predictors that might have contributed to a major 
number of goals achieved per patient. The following vari-
ables were tested: male gender (p = 0.105), age > 50 years 
(p = 0.149), diabetes (p = 0.188), dyslipidemia (p = 0.392), 
hypertension (p = 0.321), hospitalization (p < 0.0001), pa-
tient from cardiology (p < 0.0001), being treated by anoth-
er physician (p = 0.687), awareness about the importance 
of secondary prevention (p = 0.264), knowledge of reason 
for treatment (p  =  0.001), reporting the right diagnosis 
(p = 0.005), adherence to medical prescription (p = 0.430), 
physician’s advice to undergo aerobic exercise (p = 0.080), 
physician’s dietary counseling (p  =  0.528), prescription 
of acetylsalicylic acid (p  =  0.016), prescription of statin 
(p < 0.0001), prescription of β-blocker (p < 0.0001), and 
prescription of ACE inhibitors (p = 0.320). Knowing the 
reason for treatment, reporting the right diagnosis, being 
hospitalized, being from cardiology clinic, and receiving 
the prescription of statin, β-blocker or acetylsalicylic acid 
(ASA) were the factors associated with a greater number 
of goals per patient. 
The variables “knowledge of reason for treatment” and 
“reporting the right diagnosis” were both significantly as-
sociated to the independent variable, but considering their 
collinearity, only the first one was included in the linear 
regression model. According to the multivariate analysis, 
the independent predictors that contributed to a higher 
number of goals per patient were: male gender, hospital-
ization, being from cardiology clinic, knowing the reason 
for treatment, and receiving prescription of β-blocker.
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DISCUSSION
In this study, the prevalence of traditional risk factors was 
similar to that previously found in other populations; for 
example, the 77.6% hypertension rate observed is com-
patible with the range from 46% to 82.5% reported in 
five other studies that included patients with atheroscle-
rosis10,11,16,17,20. In the REACH Registry, where a total of 
55.499 patients with symptomatic CAD, PAD or cerebro-
vascular disease from 44 different countries were analyzed, 
the authors found a prevalence of hypertension, hypercho-
lesterolemia, diabetes, and smoking of 80%, 70.2%, 37.5%, 
and 14.4%, respectively8. These findings indicate the great 
potential of prevention practices in high-risk populations. 
Although it is well recognized that lifestyle modification 
is one of the most important interventions for cardiovascu-
lar risk reduction, it is often neglected and less translated 
into clinical practice than medication prescription9,10,20. 
In the present study, only 44.8% of the patients reported 
Nr. of patients
  Vascular surgery (n = 93) Cardiology (n = 99) p-value
Female gender 35 42 0.557
Diabetes 25 50 0.003
Current smokers 17 5 < 0.0001
Hypertension 71 78 0.750
Dyslipidemia 49 61 0.385
Outpatients 48 50 0.886
Being treated by another physician 67 48 0.001
Physician’s advice to quit smoking for current/ 
formers smokers
36 (n = 55) 33 (n = 51) 0.148
Physician’s aerobic exercise advice 50 61 0.307
Physician’s dietary counseling 59 77 0.039
Medication prescription for secundary prevention
ACEi 42 63 0.014
Statin 78 97 0.001
Acetylsalicylic acid 75 93 0.008
Clopidogrel 3 7 0.333
β-blocker 46 83 < 0.0001
Patient’s knowledge regarding the disease
Knowledge of reason for treatment 84 98 0.058
Reporting the right diagnosis 77 92 0.044
Awareness about the importance of secondary 
prevention
73 75 0.732
Mean values ± SD
  Vascular surgery Cardiology p-value
Age (years) 68.47 ± 10.81 (n = 93) 63.02 ± 9.51 (n = 99) < 0.0001
Systolic blood pressure (mmHg) 119.77 ± 18.31 (n = 47) 126.43 ± 21.87 (n = 98) 0.073
Diastolic blood pressure (mmHg) 69.60 ± 11.32 (n = 47) 75.35 ± 13.20 (n = 98) 0.011
HDL-C (mg/dL) 43.59 ± 12.80 (n = 71) 40.19 ± 10.38 (n = 86) 0.068
LDL-C (mg/dL) 105.44 ± 40.85 (n = 71) 98.76 ± 37.25 (n = 86) 0.289
Total cholesterol (mg/dL) 174.46 ± 47.86 (n = 71) 168.66 ± 42.49 (n = 86) 0.424
Tryglicerides (mg/dL) 136.00 ± 59.90 (n = 71) 151.69 ± 87.21 (n = 86) 0.201
Table 1 – Demographic characteristics of study participants according to the clinic of origin
ACEi, angiotensin conversion enzyme inhibitors.
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following a balanced diet, and only 25% exercised on a reg-
ular basis. The poor adherence of patients to prescription 
usually is the first factor considered to justify gaps between 
theory and practice, but in the present study, physicians’ 
adherence to guidelines recommendations comes first, as 
only 70.8% of the patients reported receiving dietary advice 
and only 57.85% were encouraged by their physicians to 
exercise. Regarding medical advice for smoking cessation, 
65% of the current and former smokers reported they were 
encouraged to quit smoking by their physicians; the 11.6% 
rate of current smokers in this study’s population, although 
not ideal, can be considered below the smoking prevalence 
in other populations with atherosclerotic disease (22%20 to 
44% in patients with PAD)17.  
The prescription of medications that improve second-
ary prevention showed better results. According to the 
reference guidelines for management of CAD and PAD 
patients1,6,7, antiplatelet therapy is the only medication that 
should be prescribed for every patient included in the study 
(unless contra-indicated): the 87.5% ASA combined with 
the 5.2% clopidogrel prescription rates were satisfactory. 
Statins were prescribed to 91.1% of the patients, 67.2% of 
them were under β -blocker therapy, and 54.7% were on 
ACE inhibitors (ACEi). Considering that systolic blood 
pressure levels were not well controlled in almost 43% of 
the patients, the ACEi and β -blockers certainly were un-
derused, and probably there was also a inadequacy in dose 
titration. The same concern is applicable to lipid control; 
despite that 91.1% of the patients received statin therapy, 
only 40.1% had LDL-cholesterol level below 100  mg/dL. 
The 8.3% rate of poor adherence to medication prescrip-
tion can also contribute to the lack of efficacy in achieving 
the desired blood pressure and lipid levels. 
Even though this reality is far from ideal, it is equal to 
or even better than reports in the literature. In the largest 
systematic review regarding secondary prevention mea-
sures for patients with PAD, published by Flu et al. in 2010, 
from the 671 analyzed patients with PAD, only 23% were 
prescribed walking exercise and only 39% of the 1.963 
patients who were current smokers received smoking 
cessation advice9. Only 63% received antiplatelet agents, 
45% received lipid-lowering medications, and 46% were 
under anti-hypertensive medication therapy. In the study 
published by Lloyd et al.11, among 313 patients with ab-
dominal aortic aneurysm (80% of them had concomitant 
peripheral arterial obstructive disease) only 60% received 
antiplatelet medication, 41% statin, 39% ACEi, and 38% 
β-blockers11. 
The average number of 3.06 out of six target goals 
achieved per patient represents an overview of the unsat-
isfactory practice of secondary prevention in this popu-
lation. Still, it is consistent with previous studies. This 
instrument of evaluation had been previously applied by 
Kinikini et al.10 to analyze the adequacy of nine preven-
tion goals to the American College of Cardiology/Ameri-
can Heart Association (ACC/AHA) secondary prevention 
guidelines recommendations in patients with peripheral 
arterial disease. In this study, 54% met the goal for blood 
pressure, 35% reported exercising, and 36% met the LDL 
cholesterol goal. These results are very similar to the pres-
ent study’s: 57% and 67% achieved the goal for systolic and 
diastolic blood pressure, 25% exercised, and 40.1% pre-
sented LDL cholesterol < 100 mg/dL. Among patients with 
diabetes, 17.3% had HbA1c < 7% in the present study and 
24% in Kinikini’s10. Notwithstanding, in that study there 
were almost seven times more current smokers than in the 
present study. The mean number of goals achieved per pa-
tient was 4.8 ± 1.5, and their 53% rate of goal compliance 
is similar to the 51% rate of this population, also very low. 
In the present study, male gender was related to a 
greater number of goals achieved per patient. Gender has 
already been pointed in literature as an important prog-
nostic factor in the specific field of secondary prevention 
for cardiovascular events. Previous data have also suggest-
ed that the suboptimal management of risk factors occurs 
mainly in women19,21,22. 
The prescription of β-blockers was another indepen-
dent factor related to the number of goals achieved per pa-
tient. There is possibly a direct influence of the medication 
in two of the six pre-defined goals (systolic and diastolic 
blood pressure control), but a β-blocker prescription could 
possibly be a marker of better medical practice.
Although secondary prevention was unsatisfactory 
both for PAD and CAD patients, it was significantly bet-
ter in the latter group. After controlling for potential con-
founding variables, such as differences between groups in 
Figure 1 – Percentage of cardiology and vascular surgery 
patients that achieved each goal. Goals marked had 
signiﬁcant difference between vascular surgery and 
cardiology patients: ap < 0.0001; bp < 0.0001; cp < 0.006, 
blood pressure.
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patient’s knowledge about their disease and different rates 
of medication prescription, CAD group remained an in-
dependent predictor of a greater number of goals achieve-
ment per patient. There are other studies that showed that 
CAD patients have better risk factor control than patients 
with other forms of atherothrombotic disease manifesta-
tion16,17,20,23. This difference is certainly related to many 
reasons, which come from physicians’ attitudes, such as 
the surgeon’s focus to procedures concerns, up to patients’ 
responsibility for their care, but the putative role of each of 
these factors remains speculative. 
In the cardiology clinic, the link between risk factor 
control and coronary artery disease management is more 
incorporated into practice; one possible reason is that, be-
sides the long-term prognostic impact of the preventive 
measures, there is also a short-term benefit in the control 
of ischemia-related symptoms, such as dyspnea and an-
gina. Vascular surgeons frequently spend too much time 
on very specific procedures’ concerns rather than sec-
ondary prevention. It has already been shown, in a study 
with general practitioners, that physicians underestimate 
the cardiovascular risk of PAD patients17, but the present 
study does not provide enough information to conclude 
whether there is a difference between cardiologists and 
vascular surgeons regarding knowledge about secondary 
prevention. 
Better cardiovascular prevention delivered for hospi-
talized patients can reflect not only on the immediate cor-
rection of eventual poor patient adherence to medications 
dosage and schedule, but also on an improvement in the 
medical care, motivated by the illness severity and facili-
tated by the longer time that physicians can spend with 
their patients. 
Knowing the reason for treatment was identified as a 
predictor of better secondary prevention. Undoubtedly, the 
patients’ responsibility and adherence to physician recom-
mendations depend on the degree of perception they have 
regarding their disease. Moreover, when patients have ac-
cess to information, they can discuss with their physicians 
and improve the resultant prescription of preventive prac-
tices. McDermott el al. has previously suggested that pa-
tients with peripheral arterial disease underestimate their 
cardiovascular risk when compared to CAD patients20. 
They compared the awareness of cardiovascular risk and 
knowledge of the importance of prevention among pa-
tients with PAD, patients with CAD, and patients without 
atherosclerotic disease. The belief regarding risks of ad-
verse cardiovascular events for hypothetical patients with 
PAD was the lowest, right among those who had PAD, 
even when they were compared to patients without ath-
erosclerosis. Hirsch et al. have also found in their United 
States population-based survey a low familiarity with PAD; 
only 25% of the 2.501 participants showed an awareness 
of PAD, in contrast to the 67.1% and 73.9% awareness of 
coronary artery disease and stroke, respectively18. An anal-
ysis focused on the subgroup of responders that claimed to 
know about PAD demonstrated that only 14% recognized 
an increased risk of death in this group18. Although it has 
already been suggested that patients’ awareness of their 
condition may influence the effectiveness of secondary 
prevention, to the authors’ knowledge, this is the first time 
that the association between patient’s awareness and better 
prevention goals has been statistically demonstrated18,20,23.
This was a transversal study and did not provide pro-
spective information regarding the implications of the 
poor secondary prevention practice. Moreover another 
limitation of this study is the fact that the only source of 
information for assessment of variables such as risk factors 
prevalence, rates of physician advice for lifestyle modifica-
tion, and patient adherence to treatment, was the patients’ 
answer during the interview. Therefore, it is possible that 
some of these rates are underestimated. In this study, pa-
tients without blood pressure measurement and lipid pro-
file for the past two years were considered as not achieving 
blood pressure control or lipid goals, based upon the rec-
ommendations for its periodical assessment. The authors 
consider that not checking these parameters can be even 
worse than obtaining a borderline value. 
The gap between real and ideal practice observed in a 
Brazilian reference university hospital certainly reflects the 
public health problem faced worldwide. Physicians’ atten-
tion to prevention goals must be enhanced, but the close 
relation between patients’ knowledge about the impor-
tance of preventive measures and the status of risk factors 
control provides an important insight to plan population 
based intervention programs and to improve the disturb-
ing reality of secondary cardiovascular prevention.
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